Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 05-2025 | 02-2025 | 11-2024 | 08-2024 | 05-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 473 | 491 | 493 | 489 | 1,262 |
| Income taxes - deferred | 169 | 122 | 183 | 106 | 118 |
| Accounts receivable | 10,972 | -6,739 | -4,971 | 2,897 | -2,891 |
| Accounts payable and accrued liabilities | 2,700 | -3,948 | N/A | -2,329 | N/A |
| Other Working Capital | 14,082 | -12,201 | -4,076 | 544 | -2,906 |
| Other Operating Activity | -15,993 | 12,531 | 8,144 | 2,897 | 4,127 |
| Operating Cash Flow | $12,403 | $-9,744 | $-227 | $4,604 | $-290 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -3 | 0 | 0 | 0 |
| Purchase Of Investment | N/A | N/A | -436 | 0 | 0 |
| Sale Of Investment | 0 | 3,202 | 543 | 779 | 1,363 |
| Purchase Sale Intangibles | 0 | -10,101 | 0 | 0 | -1,500 |
| Other Investing Activity | 0 | 0 | 59 | 0 | 0 |
| Investing Cash Flow | $-8 | $-6,902 | $166 | $779 | $-137 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 5,000 | 45,000 | 0 | N/A |
| Debt Repayment | -6,885 | -96 | -59,038 | -1,803 | -122 |
| Other Financing Activity | 0 | -239 | -4,667 | -65 | -517 |
| Financing Cash Flow | $-6,885 | $4,665 | $-18,705 | $-1,868 | $-639 |
| Exchange Rate Effect | 44 | -13 | -25 | 9 | -8 |
| Beginning Cash Position | 3,905 | 15,899 | 34,690 | 31,166 | 32,240 |
| End Cash Position | 9,459 | 3,905 | 15,899 | 34,690 | 31,166 |
| Net Cash Flow | $5,510 | $-11,981 | $-18,766 | $3,515 | $-1,066 |
| Free Cash Flow | |||||
| Operating Cash Flow | 12,403 | -9,744 | -227 | 4,604 | -290 |
| Capital Expenditure | -8 | -10,104 | N/A | N/A | -1,500 |
| Free Cash Flow | 12,395 | -19,848 | -227 | 4,604 | -1,790 |